Hydrogen Peroxide Sterilizer Market Report 2025 (Global Edition)

Global Hydrogen Peroxide Sterilizer Market Report 2025 Market Size Split by Formulation Type (liquid, vapor, plasma), by Application (Hospitals, Pharmaceutical Manufacturing, Laboratories, Ambulatory ...

Hydrogen Peroxide Sterilizer Market Report Description

We have various report editions of Hydrogen Peroxide Sterilizer Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Competitive Landscape
The hydrogen peroxide sterilizer solution market is moderately consolidated, with competition centered on technological innovation, sterilization efficiency, and digital integration. Leading manufacturers are focused on developing systems that combine safety, speed, and compatibility with hospital IT networks to streamline reprocessing workflows. Companies are increasingly embedding AI-driven features such as automated cycle validation, real-time load monitoring, and remote diagnostics to improve consistency and compliance. Additionally, there is a growing emphasis on portable and modular sterilizer designs to serve mid-sized hospitals and outpatient clinics, particularly in emerging economies. As the demand for low-temperature sterilization rises, major players are expanding their global reach through strategic partnerships, product line extensions, and regulatory approvals.

 

Recent Developments

• July 18, 2024 – Getinge Reports Strong Q2 Performance and Highlights Poladus 150 Launch

On July 18, 2024, Getinge released its interim report for April–June 2024, announcing a 15.7% increase in net sales and highlighting the launch of the Poladus 150 low-temperature sterilizer as a significant addition to its product portfolio. The report emphasized that the Poladus 150 addresses a critical need for advanced sterilization solutions in healthcare settings, contributing to the company's growth and commitment to enhancing customer value.
(Source: Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers)

• June 3, 2024 – Getinge Introduces Poladus 150 Low-Temperature Sterilizer

On June 3, 2024, Getinge unveiled the Poladus 150, a cutting-edge vaporized hydrogen peroxide (VH?O?) low-temperature sterilizer designed for reprocessing heat-sensitive surgical instruments. Operating at temperatures up to 55°C, the Poladus 150 features advanced cross-contamination barrier technology to prevent healthcare-associated infections (HCAIs). It also offers seamless integration with hospital IT systems through connectivity with FleetView and T-DOC software, enhancing instrument traceability and workflow efficiency.
(Source: Getinge introduces Poladus 150 – the future of low-temperature sterilization - Getinge)
 

Top Companies Market Share in Hydrogen Peroxide Sterilizer Industry: (In no particular order of Rank)

• Advanced Sterilization Products (ASP)
• Getinge Group
• Steris Corporation
• Shinva Medical Instrument Co.
• Ltd.
• Tuttnauer
• Belimed AG
• Metall Zug Group (Belimed division)
• Steelco S.p.A. (part of Miele Group)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region Dominates the Market?

North America stands as the leading region in the global hydrogen peroxide sterilizer solution market, driven by a combination of advanced healthcare infrastructure, stringent regulatory standards, and a proactive approach to infection control. The U.S. Food and Drug Administration (FDA) has recognized vaporized hydrogen peroxide (VHP) as an Established Category A sterilization process, aligning with international standards and encouraging its broader adoption across medical facilities.
(Source: U.S. Food and Drug Administration)
The Centers for Disease Control and Prevention (CDC) also endorses hydrogen peroxide gas plasma as an effective low-temperature sterilization method, suitable for heat-sensitive medical devices.
(Source:https://www.cdc.gov/infection-control/hcp/disinfection-and-sterilization/methods.html)
This endorsement has led to widespread implementation of hydrogen peroxide sterilizers in hospitals and clinics throughout the region.
Furthermore, the shift away from ethylene oxide, a traditional sterilants with known health risks, has accelerated the adoption of hydrogen peroxide-based sterilization. The FDA's reclassification of VHP as a safe and effective alternative underscores this transition. FDA (Source: Facilitates Broader Adoption of Vaporized Hydrogen Peroxide for Medical Device Sterilization | FDA)
In summary, North America's dominance in the hydrogen peroxide sterilizer solution market is attributed to its robust healthcare systems, regulatory support, and commitment to adopting safer, more efficient sterilization technologies.

Which is the Fastest growing Region in the Market?

The Asia-Pacific region is rapidly emerging as the fastest-growing market for hydrogen peroxide sterilizer solutions, driven by significant investments in healthcare infrastructure, a rising volume of surgical procedures, and robust government initiatives aimed at infection prevention. Countries such as China, India, and South Korea are leading this expansion, with strong emphasis on modernizing hospitals and enhancing sterilization systems in pharmaceutical and clinical settings.
In India, the Ministry of Health and Family Welfare has introduced the Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), which aims to strengthen public health infrastructure by expanding surveillance laboratories and critical care hospital units across the country. Sterilization modernization is one of the key objectives under this initiative, particularly in tertiary care facilities and district hospitals where infection control is vital.
(Source: Press Release: Press Information Bureau , https://www.mohfw.gov.in/?q=Major-Programmes/basicpage-22) 
In China, infection control has gained national attention under the Healthy China 2030 policy framework, which prioritizes modernization of hospital infrastructure and cleanroom sterilization in pharmaceutical production. According to the National Health Commission of China, healthcare reforms have led to widespread upgrades in disinfection and sterilization protocols in public hospitals.
(Source: OC.indd , http://en.nhc.gov.cn/2021-09/24/c_86717.htm) 
Moreover, the increasing number of surgical interventions across the region has elevated the need for reliable, low-temperature sterilization systems compatible with heat-sensitive instruments. In South Korea, the Korean Ministry of Health and Welfare has also promoted hospital infection prevention guidelines that emphasize the use of advanced sterilization technologies, including hydrogen peroxide vapour systems.
(Source: South Korea’s Ministry of Health and Welfare unveils 2025 action plan | Healthcare Asia Magazine , https://www.mohw.go.kr/eng/) 
As awareness of global sterilization standards continues to rise and private healthcare investment accelerates, the adoption of hydrogen peroxide sterilizers is expected to surge across Asia-Pacific, positioning the region as a key driver of growth in the global market.
 

The current report Scope analyzes Hydrogen Peroxide Sterilizer Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Hydrogen Peroxide Sterilizer Market Analysis

The hydrogen peroxide sterilizer solution market includes liquid, vapour, and plasma forms. Among these, vaporized hydrogen peroxide (VHP) dominates due to its widespread use in medical device reprocessing and cleanroom sterilization. VHP systems operate at low temperatures, making them ideal for heat-sensitive instruments while maintaining sporicidal efficacy.
Steris and ASP lead this segment with VHP sterilizers widely adopted in hospitals and biopharma facilities. Their ability to offer short cycles, no toxic residue, and high material compatibility contributes to their dominance.

 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Hydrogen Peroxide Sterilizer Industry. Request a Free Sample PDF!

Applications span hospitals, pharmaceutical manufacturing, laboratories, and ambulatory surgical centers. Hospitals remain the primary users, particularly for endoscope sterilization, robotic surgery instruments, and implant reprocessing. However, the pharmaceutical sector is emerging as a key segment due to strict sterility standards in cleanroom environments.
For example, pharmaceutical firms now rely on hydrogen peroxide bio-decontamination chambers to sterilize production lines, with regulatory agencies endorsing their use in GMP compliance. 
(Source: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice | FDA)
 

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion